NDA/BLA filedconf 0.70
Bezuclastinib — NDA/BLA filed
$COGT · Cogent Biosciences, Inc. · Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors
Event date
Date TBD
Sponsor runway
8 mo
$241.2M liquid
Evidence
Comparable historical nda/bla fileds· last 5 years · same event type
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $AXSM | — | 2025-12-31 | unknown |
| $RCKT | kresladi | 2025-10-14 | unknown |
| $ALDX | reproxalap | 2025-07-17 | unknown |
| $ETON | et-600 | 2025-07-08 | unknown |
| $BCRX | orladeyo (berotralstat) | 2025-05-14 | unknown |
| $CORT | relacorilant | 2025-03-03 | unknown |
| $ALDX | reproxalap | 2024-11-01 | unknown |
| $AXSM | axs-07 | 2024-09-04 | unknown |
| $RCKT | kresladi | 2023-10-02 | unknown |
| $GERN | imetelstat | 2023-08-21 | unknown |
Recent insider activity· ±90 days
1 insider · 0 buys · 0 sells
Gift
2026-05-19Robbins Andrew R
President and CEO
160,000 @ ——